Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BMY

Bristol-Myers Squibb Co

Dec 17 • 01:57PM ET

53.83

-0.40 -0.73 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE JNJ MRK LLY ABBV GILD AMGN AZN NVS

| Held by: SCHD VTI VOO SPY IVV VTV XLV JEPI COWZ VYM

Scroll to Statements

Index	S&P 500	P/E	18.18	EPS (ttm)	2.96	Insider Own	0.18%	Shs Outstand	2.04B	Perf Week	5.12%
Market Cap	109.59B	Forward P/E	8.98	EPS next Y	5.99	Insider Trans	-1.52%	Shs Float	2.03B	Perf Month	15.00%
Enterprise Value	144.18B	PEG	0.13	EPS next Q	1.65	Inst Own	81.03%	Short Float	1.67%	Perf Quarter	18.05%
Income	6.04B	P/S	2.28	EPS this Y	466.42%	Inst Trans	-1.55%	Short Ratio	2.01	Perf Half Y	14.93%
Sales	48.03B	P/B	5.91	EPS next Y	-7.98%	ROA	6.34%	Short Interest	33.89M	Perf YTD	-4.82%
Book/sh	9.11	P/C	6.64	EPS next 5Y	71.54%	ROE	33.84%	52W High	63.33 -15.00%	Perf Year	-3.49%
Cash/sh	8.11	P/FCF	7.16	EPS past 3/5Y	- -	ROIC	9.31%	52W Low	42.52 26.60%	Perf 3Y	-31.76%
Dividend Est.	2.46 (4.57%)	EV/EBITDA	7.60	Sales past 3/5Y	1.36% 13.06%	Gross Margin	64.33%	Volatility	2.47% 2.38%	Perf 5Y	-10.58%
Dividend TTM	2.48 (4.61%)	EV/Sales	3.00	EPS Y/Y TTM	182.66%	Oper. Margin	29.18%	ATR (14)	1.33	Perf 10Y	-21.48%
Dividend Ex-Date	Jan 02, 2026	Quick Ratio	1.17	Sales Y/Y TTM	1.26%	Profit Margin	12.57%	RSI (14)	70.22	Recom	2.50
Dividend Gr. 3/5Y	6.38% 7.57%	Current Ratio	1.27	EPS Q/Q	2949.15%	SMA20	7.10%	Beta	0.29	Target Price	54.50
Payout	-	Debt/Eq	2.75	Sales Q/Q	-0.97%	SMA50	13.92%	Rel Volume	0.48	Prev Close	54.23
Employees	34100	LT Debt/Eq	2.50	Earnings	Oct 30 BMO	SMA200	10.21%	Avg Volume	16.88M	Price	53.83
IPO	Jul 05, 1929	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.41% 3.14%	Trades		Volume	5,720,376	Change	-0.73%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-15-25	Upgrade	BofA Securities	Neutral → Buy	$61
Dec-12-25	Upgrade	Guggenheim	Neutral → Buy	$62
Nov-13-25	Initiated	Scotiabank	Sector Perform	$45
Aug-05-25	Downgrade	Daiwa Securities	Outperform → Neutral	$42
Apr-22-25	Initiated	Piper Sandler	Overweight
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$55
Dec-16-24	Upgrade	Jefferies	Hold → Buy	$70
Dec-10-24	Resumed	BofA Securities	Neutral	$63
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-13-24	Upgrade	Daiwa Securities	Neutral → Outperform
Nov-12-24	Upgrade	Leerink Partners	Market Perform → Outperform	$73
Oct-25-24	Downgrade	Citigroup	Buy → Neutral	$75 → $55
Oct-17-24	Initiated	Bernstein	Mkt Perform	$56
Jul-29-24	Downgrade	Barclays	Overweight → Equal Weight	$41
Mar-11-24	Downgrade	Societe Generale	Buy → Hold
Feb-06-24	Downgrade	Redburn Atlantic	Buy → Neutral	$77 → $54
Jan-03-24	Downgrade	BofA Securities	Buy → Neutral	$68 → $60
Nov-15-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$68 → $55
Nov-09-23	Initiated	Deutsche Bank	Hold	$55
Nov-02-23	Downgrade	Daiwa Securities	Outperform → Neutral	$68 → $54

Show Previous Ratings

Today 09:00AM	Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:34AM	Harbour BioMed and BMS sign multi-specific antibody collab (Pharmaceutical Technology)
Dec-15-25 04:36PM	Stocks Fall Ahead of US November Payroll Report (Barchart)
04:12PM	Mars buys Kellanova, Goldman Sachs makes bullish hotel calls (Yahoo Finance Video)
02:25PM	Why Bristol-Myers Squibb (BMY) Stock Is Up Today (StockStory)
09:32AM	Loading…
09:32AM	BMY Gains 13.1% in Three Months: Buy, Sell or Hold the Stock? (Zacks)
09:16AM	Here Are Mondays Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, GE Vernova, KLA Corp., Klaviyo, Las Vegas Sands, ServiceNow, and More (24/7 Wall St.)
Dec-14-25 03:07PM	2 Dividend Stocks to Double Up on Right Now (Motley Fool)
Dec-13-25 01:07PM	The Smartest Dividend Stocks to Buy With $1,000 Right Now (Motley Fool)
Dec-12-25 05:45PM	Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors (Zacks)
04:05PM	Why Arcus Biosciences Just Reversed Its 287% Eight-Month Winning Streak (Investor's Business Daily)
12:51PM	These Stocks Are Moving the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More (Barrons.com)
12:45PM	Why Bristol-Myers Squibb (BMY) Stock Is Up Today (StockStory)
10:35AM	The Best Turnaround Stock to Invest $1,000 in Right Now (Motley Fool)
10:35AM	Can Opdivo's Label Expansions Help Bristol Myers Sustain Its Momentum? (Zacks)
10:03AM	Loading…
10:03AM	Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE? (Zacks)
09:35AM	Roblox downgraded, Lululemon upgraded: Wall Street's top analyst calls (The Fly)
09:13AM	Here Are Fridays Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, Citigroup, Lululemon Athletica, PayPal, Roblox, Soundhound AI, and More (24/7 Wall St.)
09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
Dec-11-25 06:59AM	U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb's Application for Opdivo (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma (Business Wire)
Dec-10-25 04:16PM	Bristol Myers Squibb Announces Dividend Increase (Business Wire)
11:28AM	Jefferies Remains Bullish on Bristol-Myers Squibb Company (BMY) (Insider Monkey)
10:20AM	2 Pharmaceutical Stocks to Buy at a Discount (Motley Fool)
Dec-09-25 01:40PM	Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal (Zacks)
11:12AM	Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play (Zacks)
Dec-08-25 11:37PM	1 Large-Cap Stock on Our Buy List and 2 We Turn Down (StockStory)
04:30PM	Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025 (Business Wire)
01:53PM	Will Cobenfy Become a Growth Driver for BMY's Neuroscience Business? (Zacks)
12:04PM	Leerink Maintains Outperform Rating as Bristol Myers (BMY) Expands ADEPT-2 Enrollment (Insider Monkey)
Dec-06-25 12:34AM	Jim Cramer on Bristol-Myers' Recent Stock Gain: "Unbelievable" (Insider Monkey)
04:25PM	Loading…
Dec-05-25 04:25PM	Do These 3 Healthcare Stocks Need a Checkup? (Motley Fool)
09:42AM	Will Breyanzi's Label Expansion Boost BMY's CAR T Cell Therapy Sales? (Zacks)
05:00AM	Praxis soars higher; Bristol Myers CAR-T therapy wins broader use (BioPharma Dive)
Dec-04-25 08:15PM	Bristol Myers Squibbs Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL) (Business Wire)
01:42PM	Analyst Report: Convatec Group PLC (Morningstar Research)
10:29AM	BMY Gains on News of Continuation of Alzheimer's Disease Study (Zacks)
Dec-03-25 04:15PM	Why A Surprise Delay For Cobenfy Just Sparked Bristol Myers Stock (Investor's Business Daily) +5.62%
02:33PM	Shares of Bristol Myers Squibb rise despite delay in clinical trial of promising drug (MarketWatch)
02:05PM	A delayed clinical trial actually boosted Bristol Myers Squibb's stock. Here's why. (MarketWatch)
11:30AM	Why Is Sarepta Therapeutics (SRPT) Up 26.4% Since Last Earnings Report? (Zacks)
11:04AM	Bristol-Myers Stock Rises on Alzheimer's Drug Study Update (The Wall Street Journal)
09:16AM	Bristol Myers Squibb Stock Climbs on Alzheimer's Trial Update. What to Know. (Barrons.com)
09:00AM	Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
06:59AM	Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer's Disease (Business Wire)
01:57AM	Cantor Fitzgerald Maintains Price Target on Bristol-Myers (BMY) Amid Milvexian Updates (Insider Monkey)
Dec-02-25 10:24AM	Pfizer's Cancer Drugs Deliver Growth Amid Competitive Pressure (Zacks)
Dec-01-25 09:40AM	Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock (Zacks)
06:59AM	Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio (Business Wire)
Nov-30-25 09:05PM	2 Undervalued, High-Quality Companies to Buy Now and Hold Forever (Motley Fool)
02:27PM	BMY Gains Attention as Bayer Reports FXIa Trial Success (Insider Monkey)
04:05AM	2 Top Dividend Stocks to Buy and Hold (Motley Fool)
Nov-29-25 06:18AM	Should You Buy Bristol Myers Stock for Its 5.4%-Yielding Dividend? (Motley Fool)
Nov-28-25 08:35AM	Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now? (Zacks)
04:21AM	Is Bristol-Myers Stock Underperforming the S&P 500? (Barchart)
Nov-27-25 01:36PM	Will Opdivo and Opdivo Qvantig Drive BMY's Top-Line Growth? (Zacks)
01:11PM	Bristol-Myers Squibb Company (BMY): A Bull Case Theory (Insider Monkey)
03:41AM	BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi (Revised) (Zacks)
Nov-26-25 06:59AM	Bristol Myers Squibb to Participate in Citis 2025 Global Healthcare Conference (Business Wire)
Nov-25-25 02:01PM	BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi (Zacks)
06:30AM	Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment (The Daily Upside)
Nov-24-25 05:00PM	Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma (Business Wire)
10:29AM	Bristol Myers Pops On A 'Surprisingly Positive' Update From Key Rival Bayer (Investor's Business Daily)
08:37AM	Bayer's stock is jumping on a stroke drug trial - and so is Bristol Myers Squibb (MarketWatch)
07:56AM	Investors bet on newer technology and indications for CGTs (Pharmaceutical Technology)
Nov-21-25 02:37PM	Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street. (Investor's Business Daily)
08:00AM	This Medical Technology Leader Sees Profit Growth Topping 44% (Investor's Business Daily)
07:41AM	PFE's New & Acquired Drugs Drive Non-COVID Comeback as LOE Test Looms (Zacks)
Nov-20-25 01:10PM	Will Librexia ACS Study Setback Dent BMY's Cardiovascular Portfolio? (Zacks)
09:19AM	The Tech Rotation Is On and Dividend-Paying Blue-Chips Are the Winners (24/7 Wall St.)
08:12AM	Bristol Myers Squibb Company (BMY) Slipped due to Lowered EPS Guidance (Insider Monkey)
08:03AM	Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street. (Investor's Business Daily)
08:00AM	This Drugmaker Is Too Cheap to Ignore. Why Bristol Is a Buy. (Barrons.com)
Nov-19-25 10:38AM	Why GRAIL Stock Could Be Biotech's Next Big Breakout (MarketBeat)
09:00AM	Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know (Zacks)
Nov-18-25 02:25PM	Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers (Business Wire)
Nov-17-25 10:33PM	Spotting Winners: Bristol-Myers Squibb (NYSE:BMY) And Branded Pharmaceuticals Stocks In Q3 (StockStory)
10:33PM	Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers (Business Wire)
08:58AM	BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ (Zacks)
06:10AM	Stocks Set for Muted Open as Investors Await Nvidia Earnings and U.S. Jobs Data (Barchart)
Nov-15-25 10:19PM	Scotiabank Initiates Coverage on Bristol Myers (BMY) with Sector Perform Rating and $45 Target (Insider Monkey)
Nov-14-25 07:51PM	Analyst Report: ConvaTec Group PLC (Morningstar Research)
04:35PM	S&P 500 Gains and Losses Today: DoorDash Drives Higher on a New Partnership; Bristol-Myers Squibb Stock Falls (Investopedia)
04:02PM	Bristol Myers Slouches 4% After Experts Say Its Heart Drug Will Fail (Investor's Business Daily)
12:35PM	Bristol Myers Shares Sink on Yet Another Trial Failure (Barrons.com)
12:34PM	Top Stock Movers Now: StubHub, DoorDash, Netflix, and More (Investopedia)
11:41AM	Virgin Galactic misses on Q3 revenue, Bristol Myers halts drug trial (Yahoo Finance Video)
11:35AM	Stocks to Watch Friday: Walmart, Eli Lilly, Warner Bros. (The Wall Street Journal)
09:48AM	Stocks to Watch Friday: Walmart, Cidara, Warner Bros. (The Wall Street Journal)
09:43AM	Bristol Myers Slumps After Its Heart Condition Study Gets The Boot (Investor's Business Daily)
07:59AM	Pharma ETFs in Spotlight Following Robust Q3 Earnings Results (Zacks)
06:59AM	Update on Phase 3 Librexia ACS Trial (Business Wire)
Nov-13-25 11:01PM	3 Reasons to Avoid BMY and 1 Stock to Buy Instead (StockStory)
04:02PM	Top Research Reports for NVIDIA, Micron Technology & Thermo Fisher (Zacks)
01:46PM	Cytokinetics Gains 11.4% in a Week: Is There More Room for Growth? (Zacks)
01:45PM	BMY's Growth Portfolio Shines in Q3: Turning Point Ahead? (Zacks)
09:45AM	Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls (The Fly)
09:40AM	Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock (Zacks)
03:00AM	RNAi looked doomed to fail until Alnylams science chief found a way (Pharma Voice)
Nov-12-25 08:27PM	3 Healthcare Stocks Topping a 2025 List of Dividend Yields (Motley Fool)
09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOERNER CHRISTOPHER S.	Chief Executive Officer	Nov 01 '25	Option Exercise	0.00	2,964	0	2,964	Nov 04 05:18 PM
Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Nov 01 '25	Option Exercise	0.00	6,281	0	22,383	Nov 04 05:15 PM
Shanahan Karin	EVP, Chief Supply Chain & Ops	Nov 01 '25	Option Exercise	0.00	6,281	0	20,078	Nov 04 05:13 PM
Gallman Cari	EVP, General Counsel	Oct 02 '25	Option Exercise	0.00	4,558	0	13,398	Oct 06 05:22 PM
Elkins David V	EVP, Chief Financial Officer	Sep 02 '25	Sale	47.33	56,000	2,650,480	167,379	Sep 03 06:46 PM
Short Bartie Wendy	EVP, Corporate Affairs	Sep 01 '25	Option Exercise	0.00	1,235	0	6,301	Sep 03 06:42 PM
Elkins David V	Officer	Sep 02 '25	Proposed Sale	47.30	56,000	2,648,800		Sep 02 11:16 AM
Gallman Cari	EVP, General Counsel	Aug 01 '25	Option Exercise	0.00	1,061	0	9,383	Aug 05 06:01 PM
Short Bartie Wendy	EVP, Corporate Affairs	Aug 02 '25	Option Exercise	0.00	738	0	5,444	Aug 05 05:58 PM
Short Bartie Wendy	EVP, Corporate Affairs	Aug 02 '25	Sale	44.23	378	16,719	5,066	Aug 05 05:58 PM
Short Bartie Wendy	EVP, Corporate Affairs	Jun 03 '25	Option Exercise	0.00	8,040	0	8,040	Jun 04 05:37 PM
Hickey Benjamin	President, RayzeBio Org.	May 09 '25	Sale	38.01	97	3,702	0	May 13 07:03 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Apr 25 '25	Buy	47.58	4,250	202,215	83,513	Apr 29 06:14 PM
Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Apr 01 '25	Option Exercise	0.00	3,306	0	15,489	Apr 03 05:15 PM
Plenge Robert M	EVP, Chief Research Officer	Mar 10 '25	Option Exercise	0.00	11,255	0	20,148	Mar 12 09:39 PM
Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Mar 10 '25	Option Exercise	0.00	23,150	0	26,937	Mar 12 09:37 PM
Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Mar 10 '25	Option Exercise	0.00	20,423	0	22,339	Mar 12 09:35 PM
Lenkowsky Adam	EVP, Chief Commercial Officer	Mar 10 '25	Option Exercise	0.00	16,684	0	20,017	Mar 12 09:34 PM
Poole Ahn Amanda	EVP, Chief People Officer	Mar 10 '25	Option Exercise	0.00	7,164	0	8,546	Mar 12 09:32 PM
LEUNG SANDRA	EVP, General Counsel	Mar 10 '25	Option Exercise	0.00	48,718	0	386,496	Mar 12 09:32 PM
Hoch Lynelle	President, Cell Therapy Org.	Mar 10 '25	Option Exercise	0.00	7,446	0	7,920	Mar 12 09:31 PM
Holzer Phil M	SVP and Controller	Mar 10 '25	Option Exercise	0.00	7,140	0	17,870	Mar 12 09:31 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Mar 10 '25	Option Exercise	0.00	44,098	0	99,040	Mar 12 09:30 PM
Gallman Cari	EVP, Corporate Affairs	Mar 10 '25	Option Exercise	0.00	7,588	0	11,626	Mar 12 09:29 PM
Elkins David V	EVP, Chief Financial Officer	Mar 10 '25	Option Exercise	0.00	69,517	0	252,608	Mar 12 09:28 PM
BOERNER CHRISTOPHER S.	Chief Executive Officer	Mar 10 '25	Option Exercise	0.00	60,034	0	152,898	Mar 12 09:27 PM
Hickey Benjamin	President, RayzeBio Org.	Mar 01 '25	Option Exercise	0.00	3,286	0	10,419	Mar 04 05:44 PM
BOERNER CHRISTOPHER S.	Chief Executive Officer	Feb 20 '25	Buy	55.05	2,000	110,096	104,626	Feb 21 07:09 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Feb 14 '25	Buy	54.84	1,823	100,000	63,932	Feb 19 07:19 PM
Hickey Benjamin	President, RayzeBio Org.	Feb 01 '25	Option Exercise	0.00	10,078	0	10,858	Feb 04 07:05 PM
Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Feb 01 '25	Option Exercise	0.00	2,543	0	7,829	Feb 04 07:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BMY

Bristol-Myers Squibb Co

Upgrade your FINVIZ experience